GenoFocus Inc
HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phy… Read more
GenoFocus Inc - Asset Resilience Ratio
GenoFocus Inc (187420) has an Asset Resilience Ratio of 16.26% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how GenoFocus Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down GenoFocus Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩22.00 Billion | 16.26% |
| Total Liquid Assets | ₩22.00 Billion | 16.26% |
Asset Resilience Insights
- Good Liquidity Position: GenoFocus Inc maintains a healthy 16.26% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
GenoFocus Inc Industry Peers by Asset Resilience Ratio
Compare GenoFocus Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Chinyang Hold
KO:100250 |
Specialty Chemicals | 12.39% |
|
DL Holdings Co Ltd Preferred
KO:000215 |
Specialty Chemicals | 0.30% |
|
Norooholdings
KO:000320 |
Specialty Chemicals | 6.58% |
|
Noroo Holdings Co Ltd
KO:000325 |
Specialty Chemicals | 6.58% |
|
Samhwa Paint
KO:000390 |
Specialty Chemicals | 0.11% |
|
Chongqing Sanxia Paints Co Ltd
SHE:000565 |
Specialty Chemicals | 45.03% |
|
Hengyi Petrochemical Co Ltd
SHE:000703 |
Specialty Chemicals | 0.17% |
|
Guangdong Xinhui Meida Nylon Co Ltd
SHE:000782 |
Specialty Chemicals | 6.84% |
Annual Asset Resilience Ratio for GenoFocus Inc (2014–2024)
The table below shows the annual Asset Resilience Ratio data for GenoFocus Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 57.30% | ₩83.81 Billion | ₩146.26 Billion | +19.65pp |
| 2023-12-31 | 37.65% | ₩36.84 Billion | ₩97.86 Billion | +6.62pp |
| 2022-12-31 | 31.03% | ₩41.55 Billion | ₩133.91 Billion | +9.41pp |
| 2021-12-31 | 21.61% | ₩25.61 Billion | ₩118.52 Billion | -9.79pp |
| 2020-12-31 | 31.40% | ₩35.56 Billion | ₩113.23 Billion | +6.71pp |
| 2019-12-31 | 24.69% | ₩22.27 Billion | ₩90.20 Billion | +11.54pp |
| 2018-12-31 | 13.16% | ₩9.25 Billion | ₩70.33 Billion | -18.24pp |
| 2017-12-31 | 31.39% | ₩22.02 Billion | ₩70.15 Billion | -55.05pp |
| 2016-12-31 | 86.44% | ₩54.65 Billion | ₩63.23 Billion | +83.64pp |
| 2015-12-31 | 2.80% | ₩856.00 Million | ₩30.52 Billion | +2.41pp |
| 2014-12-31 | 0.39% | ₩66.00 Million | ₩16.94 Billion | -- |